Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Soleno Therapeutics Inc’s stock clocked out at $72.27, up 1.22% from its previous closing price of $71.40. In other words, the price has increased by $1.22 from its previous closing price. On the day, 0.93 million shares were traded.
Ratios:
To gain a deeper understanding of SLNO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.68 and its Current Ratio is at 15.68. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.21.
On December 02, 2024, Stifel reiterated its Buy ratingand also kept the price unchanged to $74.
Robert W. Baird reiterated its Outperform rating for the stock on December 02, 2024, and also maintained the target price at $72.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 01 ’25 when Hirano Patricia C sold 3,782 shares for $70.11 per share. The transaction valued at 265,156 led to the insider holds 27,036 shares of the business.
PATRICIA HIRANO bought 3,782 shares of SLNO for $265,156 on Apr 01 ’25. On Mar 28 ’25, another insider, Pauls Matthew, who serves as the Director of the company, sold 5,937 shares for $71.55 each. As a result, the insider received 424,797 and left with 6,500 shares of the company.
Stock Price History:
Over the past 52 weeks, SLNO has reached a high of $74.00, while it has fallen to a 52-week low of $36.93. The 50-Day Moving Average of the stock is 30.03%, while the 200-Day Moving Average is calculated to be 41.25%.
Shares Statistics:
A total of 45.70M shares are outstanding, with a floating share count of 36.40M. Insiders hold about 20.63% of the company’s shares, while institutions hold 92.22% stake in the company.
